𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

✍ Scribed by Kappos, Ludwig; Hartung, Hans-Peter; Freedman, Mark S; Boyko, Alexey; Radü, Ernst Wilhelm; Mikol, Daniel D; Lamarine, Marc; Hyvert, Yann; Freudensprung, Ulrich; Plitz, Thomas; van Beek, Johan


Book ID
122200562
Publisher
The Lancet
Year
2014
Tongue
English
Weight
353 KB
Volume
13
Category
Article
ISSN
1474-4465

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES